Effect of Midazolam on White-coat Hypertensive Dental Patients
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Intravenous sedation was used for dealing with transient hypertension, so-called white-coat
hypertension, before dental treatment. Midazolam used as a sedative also has antianxiety
effect, and the mechanism is guessed that it minimizes patients' stress, resulting in the
stability of blood pressure. The purpose of this randomized controlled trial (RCT) is to
evaluate the effect of low dose of midazolam on blood pressure and anxiety scale in
white-coat hypertensive dental patients.